Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Enter Into Definitive Merger Agreementby Mallinckrodt PharmaceuticalsMallinckrodt will acquire Questcor for approximately $5.6 Billion, creating a diversified, high-growth specialty pharmaceuticals company.